The dual-purpose database that nearly tripled in price.
A pharmaceutical group was issued a HANA audit finding for nine point four million dollars, driven by Runtime HANA holding non-SAP master data, side-car analytics applications reading from the database, and a sandbox instance counted against the production entitlement.
We rebuilt the use-case map across the HANA estate. We separated the SAP application workload from the non-SAP analytics workload and proposed a discrete Full-Use carve-out for the latter. We negotiated the dual-purpose finding into a contained capacity uplift and rewrote the entitlement letter for the remaining term.
Read the case file →